On the other hand, for IECs, SCFAs can also inhibit HDAC or act as ligands for GPCRs to play a protective role in colorectal inflammation and cancer by affecting the production of cytokines, retinoic acid and antimicrobial peptides. This evidence concerns the gene HDAC9 and cancer.